GLP-1 Weight Loss and Facial Changes: What Patients Should Know

GLP-1 medications like semaglutide and tirzepatide can drive significant weight loss, but some patients notice facial changes. Dr. Sandy Skotnicki, Marlo, and Dr. Sasha High, an obesity medicine specialist, discuss the health impacts and facial changes from weight loss. They explore how these medications work, why they’re so effective, and why facial changes—often called “facial deflation”—can occur due to fat loss, especially in the midface. Listeners will learn: How GLP-1 medications drive significant, sustained weight loss and improve overall health Why is facial volume loss a natural consequence of weight loss, not a direct drug side effect Which patients are more likely to notice changes (age, rate of weight loss, baseline facial structure) The difference between superficial and deep fat loss, and why the face is often affected first The psychological impact of looking “tired” or “aged” due to volume changes How to approach treatment with thoughtful, conservative aesthetics using Hyaluronic acid fillers and Sculptra biostimulator and discuss the timing of these procedures The key takeaway: GLP-1 medications can significantly improve health, but patients may experience changes in facial appearance due to fat loss. These changes are typically manageable rather than universal, and an informed, individualized approach can help address concerns about both medical and aesthetic outcomes. This episode is sponsored by Galderma.